Hudson Bay Capital Management LP Exagen Inc. Transaction History
Hudson Bay Capital Management LP
- $28.9 Billion
- Q1 2025
A detailed history of Hudson Bay Capital Management LP transactions in Exagen Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 166,705 shares of XGN stock, worth $978,558. This represents 0.0% of its overall portfolio holdings.
Number of Shares
166,705Holding current value
$978,558% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XGN
# of Institutions
39Shares Held
6.16MCall Options Held
3.4KPut Options Held
18.4K-
Rtw Investments, LP New York, NY1.51MShares$8.87 Million0.09% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6891KShares$5.23 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY532KShares$3.12 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$2.88 Million0.0% of portfolio
-
Morgan Stanley New York, NY486KShares$2.85 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $95.4M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...